Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in

Lin Wang1, Pei-Feng Li, Ming Geng

  • 1Department of Pathology, General Hospital of Jinan Military Command, Jinan, Shandong Province, China. gm2227@sina.com

Diagnostic Pathology
|February 26, 2013
PubMed
Abstract

Insights

Telomerase reverse transcriptase (hTERT) mRNA expression in gastric cancer (GC) correlates with drug resistance. hTERT mRNA levels can help select sensitive chemotherapy drugs for GC patients, improving adjuvant therapy outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Determining sensitive chemotherapy drugs for gastric cancer (GC) is a major challenge in adjuvant therapy.
  • Evaluating chemosensitivity and human telomerase reverse transcriptase (hTERT) mRNA expression in GC is crucial.
  • Investigating the relationship between chemosensitivity and hTERT mRNA expression is key for personalized treatment.

Purpose of the Study:

  • To evaluate the chemosensitivity of gastric cancer (GC) cells to various anticancer drugs.
  • To examine the expression levels of human telomerase reverse transcriptase (hTERT) mRNA in GC tissues.
  • To determine the correlation between hTERT mRNA expression and chemosensitivity in GC.

Main Methods:

  • Primary culture of GC cells from 68 patients.
  • MTT assay for chemosensitivity evaluation in 60 GC cases.
  • In situ hybridization for hTERT mRNA expression in 60 GC tissues and adjacent normal mucosa.

Main Results:

  • Taxol, cisplatin, and 5-fluorouracil showed higher efficacy than adriamycin and mitomycin for GC cells.
  • Chemosensitivity was associated with tumor histological types and grade.
  • Significantly increased hTERT mRNA expression in GC tissues correlated with poorer differentiation and resistance to 5-fluorouracil or adriamycin.

Conclusions:

  • hTERT mRNA expression is significantly elevated in GC compared to normal tissues.
  • hTERT mRNA expression is linked to worse differentiation and chemoresistance in GC.
  • hTERT mRNA expression serves as a potential biomarker for selecting chemotherapeutic drugs in GC patients.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.